These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11502510)

  • 21. Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding group.
    Smith HK; Beckett RP; Clements JM; Doel S; East SP; Launchbury SB; Pratt LM; Spavold ZM; Thomas W; Todd RS; Whittaker M
    Bioorg Med Chem Lett; 2002 Dec; 12(24):3595-9. PubMed ID: 12443784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peptide-deformylase inhibitors, a new class of antibiotics].
    Dubreuil L
    Presse Med; 2002 Nov; 31(38):1810-2. PubMed ID: 12497724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.
    Thorarensen A; Deibel MR; Rohrer DC; Vosters AF; Yem AW; Marshall VD; Lynn JC; Bohanon MJ; Tomich PK; Zurenko GE; Sweeney MT; Jensen RM; Nielsen JW; Seest EP; Dolak LA
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1355-8. PubMed ID: 11378353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide deformylase as an antibacterial drug target: assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells.
    Apfel CM; Evers S; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1053-7. PubMed ID: 11257015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
    Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.
    Ross JE; Scangarella-Oman NE; Miller LA; Sader HS; Jones RN
    J Clin Microbiol; 2011 Nov; 49(11):3928-30. PubMed ID: 21918031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of type II peptide deformylase from Staphylococcus aureus.
    Baldwin ET; Harris MS; Yem AW; Wolfe CL; Vosters AF; Curry KA; Murray RW; Bock JH; Marshall VP; Cialdella JI; Merchant MH; Choi G; Deibel MR
    J Biol Chem; 2002 Aug; 277(34):31163-71. PubMed ID: 12048187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eukaryotic peptide deformylases. Nuclear-encoded and chloroplast-targeted enzymes in Arabidopsis.
    Dirk LM; Williams MA; Houtz RL
    Plant Physiol; 2001 Sep; 127(1):97-107. PubMed ID: 11553738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-function relationships within the peptide deformylase family. Evidence for a conserved architecture of the active site involving three conserved motifs and a metal ion.
    Meinnel T; Lazennec C; Villoing S; Blanquet S
    J Mol Biol; 1997 Apr; 267(3):749-61. PubMed ID: 9126850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activities of peptide deformylase inhibitors against gram-positive pathogens.
    Wise R; Andrews JM; Ashby J
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1117-8. PubMed ID: 11897602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of a new antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniae.
    Roblin PM; Hammerschlag MR
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1447-8. PubMed ID: 12654690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase.
    Grant SK; Green BG; Kozarich JW
    Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biological activities and X-ray structures of oxazole hydroxamate-EcMetAP-Mn complexes.
    Huguet F; Melet A; Alves de Sousa R; Lieutaud A; Chevalier J; Maigre L; Deschamps P; Tomas A; Leulliot N; Pages JM; Artaud I
    ChemMedChem; 2012 Jun; 7(6):1020-30. PubMed ID: 22489069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural basis for the design of antibiotics targeting peptide deformylase.
    Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
    Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation.
    Mazel D; Pochet S; Marlière P
    EMBO J; 1994 Feb; 13(4):914-23. PubMed ID: 8112305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents.
    Guilloteau JP; Mathieu M; Giglione C; Blanc V; Dupuy A; Chevrier M; Gil P; Famechon A; Meinnel T; Mikol V
    J Mol Biol; 2002 Jul; 320(5):951-62. PubMed ID: 12126617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in three distinct loci cause resistance to peptide deformylase inhibitors in Bacillus subtilis.
    Duroc Y; Giglione C; Meinnel T
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1673-8. PubMed ID: 19171795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 2D-QSAR in hydroxamic acid derivatives as peptide deformylase inhibitors and antibacterial agents.
    Gupta MK; Mishra P; Prathipati P; Saxena AK
    Bioorg Med Chem; 2002 Dec; 10(12):3713-6. PubMed ID: 12413827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)- and 2-(2,2-dioxo-1,4-dihydro-2H-2lambda6-benzo[1,2,6]thiadiazin-3-yl)-N-hydroxy-acetamides as potent and selective peptide deformylase inhibitors.
    Apfel C; Banner DW; Bur D; Dietz M; Hubschwerlen C; Locher H; Marlin F; Masciadri R; Pirson W; Stalder H
    J Med Chem; 2001 Jun; 44(12):1847-52. PubMed ID: 11384231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.